{
    "title": "108_hr2061",
    "content": "The Act is titled the \"National Youth Anti-Drug Media Campaign Reauthorization Act of 2003\" and includes general improvements to the National Anti-Drug Media Campaign. The Drug-Free Media Campaign Act of 1998 is amended to the National Youth Anti-Drug Media Campaign Act, focusing on preventing drug abuse among young people, increasing awareness of adults, and encouraging parental involvement. The National Youth Anti-Drug Media Campaign Act of 1998 aims to prevent drug abuse among young people by increasing awareness among adults and encouraging parental involvement. The Director, in consultation with the Partnership for a Drug Free America, determines the overall purposes and strategy of the national media campaign. The Director is responsible for implementing a focused national media campaign to meet the purposes set forth in the Act. The Director is responsible for implementing a national media campaign to prevent drug abuse among young people, in consultation with the Partnership for a Drug-Free America. The Director approves the strategy, advertising, and purchase plan for the campaign. The Partnership recommends strategies to address national, regional, and local drug threats. The national media campaign aims to address national, regional, and local drug threats by creating advertising, excluding ads provided by other nonprofits or targeting specific audiences that cannot be reached at no cost. The Partnership for a Drug-Free America will test all advertisements before using them in the national media campaign to ensure effectiveness and industry standards are met. The Director will contract a media buying contractor to plan and purchase advertising time and space for the campaign. In section 103, amendments are made to subsection (a) regarding the strategic planning and accounting of purchases for the national media campaign. This includes changes to subparagraphs (A), (C), and (F), as well as the removal of paragraph (2). The Director must allocate sufficient funds for the national media campaign, with an exception for creative development of advertisements targeting specific audiences that cannot be reached at no cost. The Director must allocate funds for a national media campaign, excluding production costs and talent payments, to reach minority or special audiences. The Partnership for a Drug-Free America cannot provide such ads, and prior notice must be given to specific committees. Subsection (b) is amended by changing \"105\" to \"106\", and subsection (c) is replaced. In subsection (b), \"105\" is changed to \"106\", and subsection (c) is replaced with a Matching Requirement for no cost matches of advertising material. The Director must ensure that all no cost matches or in-kind contributions for advertising material relate to substance abuse prevention. Advertising material donated at no cost is exempt from sponsorship identification requirements. Additionally, the Director must ensure responsible use of federal funds, with a minimum of 85% allocated each fiscal year. The Director must ensure responsible use of federal funds, with a minimum of 85% allocated each fiscal year for the national media campaign and a cap of $5,000,000 for developing advertising material. SEC. 104. FINANCIAL AND PERFORMANCE ACCOUNTABILITY. The Director is required to conduct audits and examinations of records as specified in the Federal Property and Administrative Services Act. An independent entity must evaluate the effectiveness of the national media campaign annually using data from various studies and publications. The Director must evaluate the national media campaign annually using data from studies and publications, including the National Household Survey on Drug Abuse and other relevant sources. A report must be submitted to Congress as outlined in section 105. The Director must submit an annual report to Congress detailing the national media campaign's strategy, accomplishments, efficiency, advertising plans, responsible fund usage, and contracts with external entities. \"Authorization of $195,000,000 for the Office of National Drug Control Policy for fiscal years 2004 through 2008.\""
}